Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850

www.ahrq.gov

Contract No. 290-02-0003

Prepared by:

Southern California Evidence-based Practice Center, Santa Monica, CA

Authors

Center Director

Paul Shekelle, M.D., Ph.D.

Associate Director

Margaret Maglione, M.P.P.

Content Experts

Matthew Bidwell Goetz, M.D.

Glenn Wagner, Ph.D.

Graduate Student Assistant

Zhen Wang, M.S.

Programmer/Analyst

Lara Hilton, B.A.

Staff Assistants

Jason Carter, B.A.

Susan Chen, B.A.

Carlo Tringale, BA

Physician Reviewer

Walter Mojica, M.D.

Medical Editor

Sydne Newberry, Ph.D.

AHRQ Publication No. 07-E014

September 2007

This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders.

Suggested Citation:

Maglione M, Geotz M, Wang Z, Wagner G, Hilton L, Carter J, Tringale C, Newberry S, Shekelle P. Antiretroviral (ARV) Drug Resistance in the Developing World. Evidence Report/ Technology Assessment No. 156. (Prepared by the Southern California Evidence-based Practice Center, under Contract No. 290-02-0003). AHRQ Publication No. 07-E014. Rockville, MD: Agency for Healthcare Research and Quality. September 2007.

This report is based on research conducted by the Southern California Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0003). The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.

This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

Financial Disclosure Statement: No investigators have any affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in the report.